Evidation Partners with HealthVerity to Enhance its Research and Virtual Health Offerings

Evidation and HealthVerity have announced a collaboration to provide greater transparency to the patient experience by allowing individuals to connect their wearable and survey data with real-world data from clinical settings via HealthVerity. The partnership will enable researchers and developers of health programs to be more responsive to individuals’ unique health considerations, correlating activities, behaviors, and outcomes in real life with data from clinical settings.

Based on per-use consent, people can choose to share electronic medical records, medical and pharmacy claims, and lab data, along with data from Evidation’s Achievement app that could include wearable, activity, and survey data. In doing so, researchers will be able to better understand, detect, and treat diseases faster.

Characterizing patients’ lived experiences is especially significant in the context of cardiometabolic, autoimmune, respiratory, neurological, and infectious diseases, where capturing the continuous patient journey from clinic to real life is complex and critical to impact-driven research, care delivery, and product development.

Both Evidation and HealthVerity have a strong commitment to individual privacy and control. Evidation will continue its privacy-first practice of obtaining consent on a per-use basis.

HealthVerity manages what it calls the largest real-world data ecosystem in the U.S., comprised of more than 150 billion de-identified transactions on 330 million Americans from 75 major data providers. HealthVerity’s patient identity resolution technology allows its customers to connect and exchange data in a seamless, privacy-protected manner.

Evidation’s Achievement platform is the largest digital health network in the United States, with more than 4 million individuals from nine out of 10 U.S. zip codes. Achievement has been the basis for pioneering real-world studies across diverse disease and therapeutic areas from autoimmune conditions and Alzheimer’s disease to respiratory conditions and COVID-19.

Evidation and HealthVerity will host a webinar with an introduction to the partnership and its capabilities on May 5, 2021, at 1 p.m. ET/10 a.m. PT.

Read the original press release here.